<![CDATA[Pfizer, Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=24881>Sat, 04 Apr 2026 17:20:54 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Merck, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer]]>https://www.newswire.co.kr/newsRead.php?no=814359Tue, 05 Jan 2016 10:20:00 +0900<![CDATA[Merck and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab]]>https://www.newswire.co.kr/newsRead.php?no=813529Wed, 23 Dec 2015 10:30:00 +0900<![CDATA[Merck and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers]]>https://www.newswire.co.kr/newsRead.php?no=812289Thu, 10 Dec 2015 13:55:00 +0900<![CDATA[Pfizer and Allergan to Combine]]>https://www.newswire.co.kr/newsRead.php?no=810578Tue, 24 Nov 2015 10:25:00 +0900<![CDATA[Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI® (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)]]>https://www.newswire.co.kr/newsRead.php?no=810149Thu, 19 Nov 2015 10:50:00 +0900<![CDATA[Merck and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma]]>https://www.newswire.co.kr/newsRead.php?no=810146Thu, 19 Nov 2015 10:45:00 +0900<![CDATA[Merck and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer]]>https://www.newswire.co.kr/newsRead.php?no=808703Thu, 05 Nov 2015 12:10:00 +0900<![CDATA[Merck and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma]]>https://www.newswire.co.kr/newsRead.php?no=805833Thu, 08 Oct 2015 17:45:00 +0900<![CDATA[머크-화이자, 전이성 메르켈세포암 치료 위한 임상용 면역치료제 아벨루맵의 FDA 신속심사 자격획득 발표]]>https://www.newswire.co.kr/newsRead.php?no=805834Thu, 08 Oct 2015 17:45:00 +0900<![CDATA[Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma]]>https://www.newswire.co.kr/newsRead.php?no=804745Tue, 29 Sep 2015 13:00:00 +0900<![CDATA[Merck and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab]]>https://www.newswire.co.kr/newsRead.php?no=804640Fri, 25 Sep 2015 10:15:00 +0900<![CDATA[Merck and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015]]>https://www.newswire.co.kr/newsRead.php?no=803280Fri, 11 Sep 2015 18:50:00 +0900<![CDATA[Merck and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody]]>https://www.newswire.co.kr/newsRead.php?no=791810Thu, 14 May 2015 12:00:00 +0900